Prospective randomaized study of interscalene brachial plexus block using 0.5% bupivacaine Hcl with or without dexamethasone in shoulder surgery

Not Applicable

• Conditions: Surgery; shoulder surgery; Anaesthesia

• Registration Number: PACTR201611001848252
• Lead Sponsor: alexandria university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

age ¿18 and ¿ 70 yr,
ASA I¿II,
BMI < 35

Exclusion Criteria

patient refusal

contraindication to interscalene block (severe chronic obstructive pulmonary disease, infection, coagulopathy, contralateral diaphragmatic paralysis)

pregnancy

neuropathy of the surgical limb

recent (less than six months) use of glucocorticoids for at least two weeks

chronic pain requiring daily use of opioid medication (greater than 30 mg/day of oral oxycodone equivalent).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. To determine the duration of analgesia (time to first analgesic request) after interscalene blocks when dexamethasone is added to bupivacaine for patients undergoing painful shoulder surgeries 2. To evaluate any difference in postoperative pain scores after interscalene block due to adding dexamethasone.

Secondary Outcome Measures

Name	Time	Method
1. To evaluate the effect of low volume of bupivcaine versus high volume adding on postoperative pain. 2. To determine any increase in incidence of complications of interscalene blocks due to high versus low volume of bupivcaine and with adding dexamethasone.